Dawnrays Pharmaceutical (Holdings) Limited (2348.HK)
HKD 1.16
(0.0%)
HKD 1.16
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 338.4 Million | 434.26 Million | 393.13 Million | 302.9 Million | 275.83 Million | 274.29 Million |
| Net Income | 414.05 Million | 358.05 Million | 358.17 Million | 268.13 Million | 255.43 Million | 303.96 Million |
| Depreciation & Amortization | 83.89 Million | 64.39 Million | 56.36 Million | 55.94 Million | 53.22 Million | 50.97 Million |
| Deferred income taxes | - | 127.09 Million | -16.7 Million | 17.26 Million | 58.26 Million | 59.56 Million |
| Stock-based compensation | -1.01 Million | -4.91 Million | 4.32 Million | 8.1 Million | 4.18 Million | 5.31 Million |
| Change in working capital | 22.25 Million | -122.18 Million | 12.38 Million | -25.37 Million | -62.44 Million | -64.88 Million |
| Other non-cash items | -164.77 Million | 11.81 Million | -21.39 Million | -21.16 Million | -32.81 Million | -80.64 Million |
| Investing Cash Flow | -387.57 Million | -175.01 Million | -284.2 Million | 26.44 Million | -598.85 Million | -12.73 Million |
| Investments in PPE | -212.01 Million | -204.36 Million | -313.06 Million | -139.1 Million | -33.81 Million | -16.86 Million |
| Acquisitions | - | 12.15 Million | 38.76 Million | -40 Million | -341.79 Million | 2.75 Million |
| Investment purchases | -844.48 Million | -745.81 Million | -586.07 Million | -1.45 Billion | -636.47 Million | -627.15 Million |
| Sales/Maturities of investments | 711.17 Million | 720.32 Million | 685.76 Million | 1.64 Billion | 451.25 Million | 577.46 Million |
| Other Investing Activities | -188.02 Million | 42.69 Million | -109.6 Million | 11.83 Million | -38.02 Million | 51.05 Million |
| Financing Cash Flow | 2.07 Million | -92.7 Million | -129.75 Million | -327.69 Million | 66.08 Million | -204.19 Million |
| Debt repayment | -120.06 Million | -439 Thousand | -1.04 Million | -59 Thousand | -31 Thousand | -102.76 Million |
| Dividends payments | -117.07 Million | -99.54 Million | -143.91 Million | -81.61 Million | -102.87 Million | -203.04 Million |
| Common Stock Repurchased | - | 92 Thousand | -15.53 Million | -40.27 Million | -43.28 Million | - |
| Common Stock Issuance | 1.17 Million | 347 Thousand | 2.19 Million | 40.33 Million | 43.31 Million | - |
| Other Financing Activities | 120.7 Million | 6.84 Million | 28.54 Million | -246.08 Million | 168.96 Million | -3.56 Million |
| Accounts receivables | 73.38 Million | -79.81 Million | -27.07 Million | 40.24 Million | -23.37 Million | -33.58 Million |
| Accounts payables | - | -36.26 Million | -5.27 Million | 894 Thousand | -12.45 Million | - |
| Inventory | 19.7 Million | -42.36 Million | 39.45 Million | -65.61 Million | -39.06 Million | -31.29 Million |
| Other working capital | -8.61 Million | 36.26 Million | 5.27 Million | -894 Thousand | 12.45 Million | -1.36 Million |
| Cash at beginning of period | 411.68 Million | 237.74 Million | 258.48 Million | 258.62 Million | 525.36 Million | 460.74 Million |
| Cash at end of period | 366.82 Million | 411.68 Million | 237.74 Million | 258.48 Million | 258.62 Million | 525.36 Million |
| Capital Expenditure | -212.01 Million | -204.36 Million | -313.06 Million | -139.1 Million | -33.81 Million | -16.86 Million |
| Effect of forex changes on cash | 2.24 Million | 7.38 Million | 75 Thousand | -1.78 Million | -9.8 Million | 7.25 Million |
| Net cash flow / Change in cash | -44.85 Million | 173.93 Million | -20.74 Million | -134.99 Thousand | -266.74 Million | 64.61 Million |
| Free Cash Flow | 126.38 Million | 229.9 Million | 80.07 Million | 163.8 Million | 242.02 Million | 257.43 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 414.05 Million | 70.05 Million | 255.94 Million | 358.05 Million | 186.39 Million | 171.66 Million |
| Depreciation & Amortization | 83.89 Million | 19.55 Million | 62.29 Million | 64.39 Million | 23.61 Million | 40.77 Million |
| Deferred income taxes | - | - | -19.34 Million | 127.09 Million | 172.85 Million | -45.75 Million |
| Stock-based compensation | -1.01 Million | 364 Thousand | -1.38 Million | -4.91 Million | 955 Thousand | -5.86 Million |
| Change in working capital | 22.25 Million | 60.63 Million | 23.83 Million | -122.18 Million | -157.94 Million | 72.02 Million |
| Other non-cash items | -164.77 Million | -4.68 Million | -148.21 Million | 11.81 Million | 111.94 Million | -9.29 Million |
| Investing Cash Flow | -387.57 Million | -183.55 Million | -204.02 Million | -175.01 Million | 74.1 Million | -249.11 Million |
| Investments in PPE | -212.01 Million | -31.65 Million | -167.89 Million | -204.36 Million | -34.68 Million | -169.67 Million |
| Acquisitions | - | - | - | 12.15 Million | -8.64 Million | - |
| Investment purchases | -844.48 Million | - | - | -745.81 Million | - | - |
| Sales/Maturities of investments | 711.17 Million | - | - | 720.32 Million | - | - |
| Other Investing Activities | -188.02 Million | -151.89 Million | -36.12 Million | 42.69 Million | 117.43 Million | -79.43 Million |
| Financing Cash Flow | 2.07 Million | 72.6 Million | -70.53 Million | -92.7 Million | -16.12 Million | -76.57 Million |
| Debt repayment | -120.06 Million | - | -892 Thousand | -439 Thousand | - | -523 Thousand |
| Dividends payments | -117.07 Million | -21.03 Million | -96.03 Million | -99.54 Million | -20.17 Million | -79.37 Million |
| Common Stock Repurchased | - | - | - | 92 Thousand | - | - |
| Common Stock Issuance | 1.17 Million | - | - | 347 Thousand | - | - |
| Other Financing Activities | 120.7 Million | 93.64 Million | 26.39 Million | 6.84 Million | 4.04 Million | 3.32 Million |
| Accounts receivables | 73.38 Million | 68.28 Million | 5.09 Million | -79.81 Million | -120.55 Million | 40.74 Million |
| Accounts payables | - | - | - | -36.26 Million | - | - |
| Inventory | 19.7 Million | 4.06 Million | 15.63 Million | -42.36 Million | -53.24 Million | 10.88 Million |
| Other working capital | -8.61 Million | -11.71 Million | 3.1 Million | 36.26 Million | 15.86 Million | 20.4 Million |
| Cash at beginning of period | 411.68 Million | 331.14 Million | 411.68 Million | 237.74 Million | 186.57 Million | 237.74 Million |
| Cash at end of period | 366.82 Million | 331.14 Million | 331.14 Million | 411.68 Million | 411.68 Million | 186.57 Million |
| Capital Expenditure | -212.01 Million | -31.65 Million | -167.89 Million | -204.36 Million | -34.68 Million | -169.67 Million |
| Effect of forex changes on cash | 2.24 Million | 692 Thousand | 1.55 Million | 7.38 Million | 2.17 Million | 5.21 Million |
| Net cash flow / Change in cash | -44.85 Million | - | -80.53 Million | 173.93 Million | 225.1 Million | -51.16 Million |
| Free Cash Flow | 126.38 Million | 114.27 Million | 24.57 Million | 229.9 Million | 130.27 Million | 99.62 Million |
TILT
SKSUY
EOG
ROS
600160
9555